Position history for BlackRock, Inc.'s holdings in Inhibrx Biosciences, Inc.
BlackRock, Inc. holds 777,383 shares of INBX (Inhibrx Biosciences, Inc.), worth $61.4M as of 2025-Q4. The position was increased (++13.5% shares). INBX represents 0.0% of BlackRock, Inc.'s portfolio.
Current Value
$61.4M
Current Shares
777,383
Total Value Change
+$48.6M
Total Shares Change
-54,424
Other major holders of INBX: VIKING GLOBAL INVESTORS LP, MORGAN STANLEY, HighTower Advisors, LLC, VANGUARD GROUP INC
Increased |
| 777,383 |
+13.5% |
| $61.4M |
| 0.0% |
| $77.98 |
33 |
| 2025-Q3 | Decreased | 684,746 | -6.0% | $23.1M | 0.0% | $32.31 | 0 |
| 2025-Q2 | Decreased | 728,744 | -12.5% | $10.4M | 0.0% | $14.43 | 0 |
| 2025-Q1 | Increased | 832,732 | +0.1% | $11.6M | 0.0% | $14.12 | 28 |
| 2024-Q4 | New | 831,807 | - | $12.8M | 0.0% | $15.14 | 39 |